Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

ODM-204 MeSH Supplementary Concept Data 2025


MeSH Supplementary
ODM-204
Unique ID
C000656535
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000656535
Entry Term(s)
4-(((1R)-3-Imidazol-1-yl-6,6-dimethylcyclohex-2-en-1-yl)-methylamino)-2-(trifluoromethyl)benzonitrile
Registry Numbers
0
Heading Mapped to
*Imidazoles
Frequency
3
Note
nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1
Source
J Steroid Biochem Mol Biol, 192, 105115. Sep 2019
Date of Entry
2020/01/21
Revision Date
2020/01/21
ODM-204 Preferred
4-(((1R)-3-Imidazol-1-yl-6,6-dimethylcyclohex-2-en-1-yl)-methylamino)-2-(trifluoromethyl)benzonitrile Broader
page delivered in 0.005s